The Latest Breaking News on Mental health

Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.

IGC Pharma, Inc.(NYSE:IGC) reported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents. 

Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company"))), a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer's disease (AD) dementia, today announced

Early instruction that teaches young people how to recognise negative thought patterns and manage their mental health may help to avoid problems in later life

The colder months are already a challenge, writes Jess Watts. Add to that an all-encompassing fear of getting sick – as I have – and it becomes nearly impossible

Alzheimer's disease may cause brain damage in two stages, according to new research supported by the National Institutes of Health (NIH) that uses sophisticated brain mapping methods. Read further on Dynamite News:

Director Elizabeth Sankey’s free-ranging film uses interviews with actors and support groups alongside clips of cinematic covens to draw parallels with her own experiences

The researchers noted that in those with a moderate to high genetic risk of dementia, high cardiovascular fitness reduced their risk of developing dementia by 35%.

TV presenter McCall underwent surgery last week after being diagnosed with a ‘very rare’ benign brain tumour, known as a colloid cyst